Early Clinical Trial Data Show Gene Therapy Reversing Sickle Cell Anemia
December 04, 2018
December 04, 2018
CINCINNATI, Ohio, Dec. 4 -- The Cincinnati Children's Hospital Medical Center issued the following news release:
* * *
- Treatment Uses Reduced-Intensity Preconditioning to Enhance Its Global Transportability
After over a decade of preclinical research and development, a new gene therapy treatment for sickle cell anemia (SCA) is reversing disease symptoms in two adults and showing early potential for transportability to resource-challenged parts of the worl . . .
* * *
- Treatment Uses Reduced-Intensity Preconditioning to Enhance Its Global Transportability
After over a decade of preclinical research and development, a new gene therapy treatment for sickle cell anemia (SCA) is reversing disease symptoms in two adults and showing early potential for transportability to resource-challenged parts of the worl . . .